What's breaking now, across thousands of outlets.
GLP-1 weight-loss drug eligibility depends on BMI, specific health conditions and medical history, and these 14 points show who FDA labels for Wegovy, Zepbound and Saxenda include and exclude
We haven't written up this one. Quartz has the full story — the link below goes straight to it.
Industries affected by GLP-1 drugs like Ozempic and Zepbound range from drugmakers and pen manufacturers to diet programs, snack makers and insurers, with mixed and uncertain effects
Take-Two Interactive has published its financial results for its second fiscal quarter, with net bookings down 18% to $1.60 billion and net revenue down 16% to $1.50 billion. Read more
La patronne de Fayard est nommée directrice générale déléguée de Grasset, sept mois après le limogeage d’Olivier Nora. Elle arrive dans une maison vidée de ses auteurs et dont les salariés souhaitent…
Booze brands are hopeful that help is on the way for their industry – and they need it. Tariffs and declining drinking habits have weighed heavily on beverage companies over the last two years, but…
Prisene på forsikring øker mer enn i andre bransjer. - Privatkunder betaler for økt lønnsomhet, sier…
When a founder becomes the face of a trillion-dollar empire, a personal scandal isn’t just private drama—it’s a product failure.
